Grant Details
Grant Number: |
5R01CA090648-02 Interpret this number |
Primary Investigator: |
Collet, Jean-Paul |
Organization: |
Sir Mortimer B. Davis Jewish Gen Hosp |
Project Title: |
Tricyclic Antidepressants as Risks Factors for Cancer |
Fiscal Year: |
2002 |
Abstract
DESCRIPTION: Rational and Aims: Although mechanisms have not been confirmed,
animal and epidemiological studies suggest that antidepressants promote tumor
growth in humans. Recently, a study in animals showed that tricyclic
antidepressants (TCAs) with a nitrogen atom at position 5 in the 7-membered
ring of their chemical structure (5-N) were genotoxic, as compared to those
with a carbon atom at the same position (5-C) (Van Schaik et al. Mutation
Research 1993, 286(2): 155-163). These results were confirmed in humans by a
large epidemiologic study (Sharpe et al. submitted to the British Journal of
Cancer, 2000). In this historical population-based case-control study we will
investigate the effect of past exposure to 5-N TCAs on the risk of developing
cancer at 19 different sites.
Methods: The source population for the study will be the dynamic cohort defined
by membership in the Saskatchewan Prescription Drug Plan (SPDP). Incident
cancer cases (at one of the 19 sites considered) over 5 years of age will be
accrued by the provincial cancer registry from 1981 to 1999. At least 4
controls/case will be selected from the source population, matched on age,
gender, and calendar time, using incidence density sampling. Detailed drug
exposure data over a minimum of 5 years before diagnosis and up to a maximum of
23 years will be obtained from the SPDP. We will study for each drug and each
site the respective effects of dosage, timing of use, and duration of use.
Significance: If the results show that long-term use of antidepressants affect
the incidence of cancer, they will be relevant to clinicians (with an
elaboration on the risk/benefit profile of this therapy) and to the
pharmaceutical industry (with a view to modifying the structure of drugs to
enhance their beneficial effects and to reduce their harmful effects).
Publications
None